- EN
Table TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering treatment, 2011 or most recent year available
Part (ii) Inpatient units
| Country | Males | Females | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean age at first use | Mean age at entering treatment | Time lag between first use and first treatment demand | Mean age at first use | Mean age at entering treatment | Time lag between first use and first treatment demand | Mean age at first use | Mean age at entering treatment | Time lag between first use and first treatment demand | ||
| Opiods | 22 | 31 | 9 | 22 | 31 | 9 | 22 | 31 | 9 | |
| Cocaine | 21 | 32 | 11 | 21 | 31 | 10 | 21 | 32 | 11 | |
| Stimulants | 20 | 29 | 9 | 19 | 26 | 7 | 20 | 28 | 8 | |
| Cannabis | 17 | 26 | 9 | 17 | 25 | 8 | 17 | 26 | 9 | |
Notes:
For information relative to the countries included, please see Table TDI-7
See also ‘General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2012 — inpatient treatment centres.